APEC 2024 Peru. Biden shafted to a corner in the back row. Xi in front row next to Peru's President
1/13/2008
The Mean Dilemma
While everyone is being worked up in this mean thing, wanting to be mean but trying to be not so mean, have we forgotten about the basic problem, the unstoppable rising medical cost? Or is Mean Testing a solution to solving this problem or just a diversion, that reducing cost can quietly be swept under the carpet?
I am getting some inspiration from President Suharto on how to make more money to subsidise those who are trying to stretch their dollar and savings to last longer. The rich, like Suharto, will not be embarrassed by Mean Testing. They can afford to pay. And he is paying, I hope so, for every day he spent being hooked up to all the machines and surrounded by an entourage of expensive medical professionals.
This is a very lucrative market to tap on. Hospitals, private and public, should allocate more resources to provide such services and support to the very rich and charge them accordingly, and no subsidies of course. They don't mind being hooked on to machines and enjoy the publicity. Though this is what advanced medical science can do to hold on to a dying piece of living tissue, it is important for those who can afford to live this way.
There are plenty of money to be made. Market the business aggressively so that the very rich can pay for the not so rich or the poorer people.
It is time to restructure the whole medical profession and medical business to pursue more profits with a good reason and not continuously lumping the cost to those who can barely afford to pay.
With the fear of being sick and admitted to hospitals growing by the days, no one can blame those with a few dollars in their savings, including those in Medisave, to want to hold on to them for as long as possible. No one should harbour the thought of emptying the people's life savings for their own medical care as quickly as possible under whatever schemes. For whatever there is in the Medisave may not be enough.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment